<DOC>
	<DOCNO>NCT00658346</DOCNO>
	<brief_summary>Infections HIV-1 group O find 1 3 % person live HIV Cameroon . The natural history treatment response well understood . The natural resistance non nucleoside reverse transcriptase inhibitor possible low sensitivity protease inhibitor complicate choice adequate treatment option . This observational study aim evaluate antiretroviral treatment response HIV-1 group O infect patient comparison HIV-1 group M infect patient . The propose standardized follow-up facilitate well understanding natural history treatment specificity improve patient management . This non randomized study , open label , standardize follow-up . A total 171 patient</brief_summary>
	<brief_title>Molecular Diversity HIV-1 Group O Strains Treatment Management Cameroon</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<criteria>HIV1 group O group M infection No history antiretroviral treatment ( except PMTCT ) Criteria treatment initiation accord Cameroons national guideline Ongoing traditional treatment could interfere hepatic function Ongoing treatment rifabutin , rifampicin rifampin Acute hepatitis B infection Pregnancy lactate mother HIV1 group O group M coinfection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>HIV-1 group O</keyword>
	<keyword>HIV-1 group M</keyword>
	<keyword>Cameroon</keyword>
	<keyword>HIV-1 infection</keyword>
	<keyword>treatment na√Øve</keyword>
</DOC>